LifeVantage to Announce Second Quarter Fiscal Year 2023 Results on February 2, 2023

Rhea-AI Summary

LifeVantage Corporation (Nasdaq: LFVN) will announce its financial results for the second quarter ended December 31, 2022, on February 2, 2023, after the market closes. The company will host a conference call for investors at 2:30 p.m. MT (4:30 p.m. ET). Interested parties can call (877) 704-4453 in the U.S. or (201) 389-0920 internationally to participate. A replay will be available until February 9, 2023. Additionally, a live webcast will be accessible on the company’s Investor Relations website and archived for 30 days.

Positive

• Upcoming conference call on February 2, 2023, may provide key insights into financial performance.
• Live webcast options enhance accessibility for investors.

Negative

• None.

SALT LAKE CITY, Jan. 19, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its second quarter ended December 31, 2022, after the stock market closes on Thursday, February 2, 2023. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, February 9, 2023, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13735667, or (412) 317-6671 from international locations, and entering confirmation code 13735667.

There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1594115&tp_key=921deb41f0. The webcast will be archived for approximately 30 days.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim^® family of products, LifeVantage^® Omega+™, ProBio™, IC Bright^®, and Daily Wellness™ dietary supplements, the TrueScience^® line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim^®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio^® its nootropic energy drink mixes, and PhysIQ™, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contact:

Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com

 

FAQ

When will LifeVantage release its Q2 financial results?

LifeVantage will release its Q2 financial results on February 2, 2023.

What time is the LifeVantage conference call?

The conference call is scheduled for 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on February 2, 2023.

How can I participate in the LifeVantage investor call?

Investors can dial (877) 704-4453 from the U.S. or (201) 389-0920 from international locations.

Is there a replay available for the LifeVantage conference call?

Yes, a replay will be available until February 9, 2023.

Where can I watch the LifeVantage earnings call webcast?

The webcast will be available on the Investor Relations section of LifeVantage's website.